CLINICAL_TRIALS
trial_result
· 2022-08-02
Clinical Trial Update: Zelquistinel in the Treatment of Major Depressive Disorder [Phase 2]
Summary
A Phase 2 trial evaluating Zelquistinel for major depressive disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Syndeio Biosciences, Inc | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2022-08-02